The quality of oral anticoagulation in general practice in patients with atrial fibrillation

Piccini, 2012, Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993–2007, Circ Cardiovasc Qual Outcomes, 5, 85, 10.1161/CIRCOUTCOMES.111.962688 Wilke, 2012, Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients, Europace Heeringa, 2006, Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, Eur Heart J, 27, 949, 10.1093/eurheartj/ehi825 Camm, 2012, 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association, Europace, 14, 1385, 10.1093/europace/eus305 Fuster, 2011, ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Circulation, 123, e269, 10.1161/CIR.0b013e318214876d Singer, 2008, Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 546S, 10.1378/chest.08-0678 Wilke, 2012, Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients, Thromb Haemost, 107, 1053, 10.1160/TH11-11-0768 Ogilvie, 2010, Underuse of oral anticoagulants in atrial fibrillation: a systematic review, Am J Med, 123, 638, 10.1016/j.amjmed.2009.11.025 Lee, 2011, Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure, J Thromb Thrombolysis, 31, 249, 10.1007/s11239-011-0555-z Reynolds, 2004, Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis, Chest, 126, 1938, 10.1378/chest.126.6.1938 Morgan, 2009, Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control, Thromb Res, 124, 37, 10.1016/j.thromres.2008.09.016 Wallentin, 2010, Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial, Lancet, 376, 975, 10.1016/S0140-6736(10)61194-4 Abdelhafiz, 2001, A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation, Clin Ther, 23, 1628, 10.1016/S0149-2918(01)80134-X Dolan, 2008, Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature, Curr Med Res Opin, 24, 1459, 10.1185/030079908X297349 McBride, 2007, Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice, J Thromb Thrombolysis, 24, 65, 10.1007/s11239-006-0002-8 Verhovsek, 2008, Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review, BMC Geriatr, 8, 13, 10.1186/1471-2318-8-13 van Walraven, 2006, Effect of study setting on anticoagulation control: a systematic review and metaregression, Chest, 129, 1155, 10.1378/chest.129.5.1155 Friberg, 2012, Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, Eur Heart J, 33, 1500, 10.1093/eurheartj/ehr488 Bonnemeier, 2011, Presentation of atrial fibrillation and its management by cardiologists in the ambulatory and hospital setting: MOVE cross-sectional study, Curr Med Res Opin, 27, 995, 10.1185/03007995.2011.563286 Flaker, 2010, Cognitive function and anticoagulation control in patients with atrial fibrillation, Circ Cardiovasc Qual Outcomes, 3, 277, 10.1161/CIRCOUTCOMES.109.884171 Melamed, 2011, Quality of anticoagulation control among patients with atrial fibrillation, Am J Manag Care, 17, 232 Costa, 2011, Quality of management of oral anticoagulation as assessed by time in therapeutic INR range in elderly and younger patients with low mean years of formal education: a prospective cohort study, Age Ageing, 40, 375, 10.1093/ageing/afr020 Baker, 2011, INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center, J Manag Care Pharm, 17, 133 Waterman, 2004, Effect of warfarin nonadherence on control of the International Normalized Ratio, Am J Health Syst Pharm, 61, 1258, 10.1093/ajhp/61.12.1258 Rabin, 2001, EQ-5D: a measure of health status from the EuroQol Group, Ann Med, 33, 337, 10.3109/07853890109002087 Bullinger, 1998, Translating health status questionnaires and evaluating their quality: the International Quality of Life Assessment project approach, J Clin Epidemiol, 51, 913, 10.1016/S0895-4356(98)00082-1 Kirchhof, 2007, Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association, Europace, 9, 1006, 10.1093/europace/eum191 Dorian, 2009, Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale, Circ Arrhythm Electrophysiol, 2, 218, 10.1161/CIRCEP.108.812347 Kripalani, 2009, Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease, Value Health, 12, 118, 10.1111/j.1524-4733.2008.00400.x Wilke, 2011, Toward identifying the causes and combinations of causes increasing the risks of nonadherence to medical regimens: combined results of two German self-report surveys, Value Health, 14, 1092, 10.1016/j.jval.2011.06.002 Rosendaal, 1993, A method to determine the optimal intensity of oral anticoagulant therapy, Thromb Haemost, 69, 236, 10.1055/s-0038-1651587 Anderson, 2007, Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation, Circulation, 116, 2563, 10.1161/CIRCULATIONAHA.107.737312 van der Heijden, 2006, Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example, J Clin Epidemiol, 59, 1102, 10.1016/j.jclinepi.2006.01.015 Boulanger, 2006, Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice, Int J Clin Pract, 60, 258, 10.1111/j.1368-5031.2006.00790.x Kim, 2009, How well does the target INR level maintain in warfarin-treated patients with non-valvular atrial fibrillation?, Yonsei Med J, 50, 83, 10.3349/ymj.2009.50.1.83 Matchar, 2002, Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial, Am J Med, 113, 42, 10.1016/S0002-9343(02)01131-2 Wieloch, 2011, Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA, Eur Heart J, 32, 2282, 10.1093/eurheartj/ehr134